HRP20010042B1 - Newcastle disease virus infectious clones, vaccines and diagnostic assays - Google Patents
Newcastle disease virus infectious clones, vaccines and diagnostic assaysInfo
- Publication number
- HRP20010042B1 HRP20010042B1 HR20010042A HRP20010042A HRP20010042B1 HR P20010042 B1 HRP20010042 B1 HR P20010042B1 HR 20010042 A HR20010042 A HR 20010042A HR P20010042 A HRP20010042 A HR P20010042A HR P20010042 B1 HRP20010042 B1 HR P20010042B1
- Authority
- HR
- Croatia
- Prior art keywords
- vaccines
- newcastle disease
- disease virus
- diagnostic assays
- virus infectious
- Prior art date
Links
- 241000711404 Avian avulavirus 1 Species 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002458 infectious effect Effects 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000271566 Aves Species 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18141—Use of virus, viral particle or viral elements as a vector
- C12N2760/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98202054A EP0974660A1 (en) | 1998-06-19 | 1998-06-19 | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
PCT/NL1999/000377 WO1999066045A1 (en) | 1998-06-19 | 1999-06-17 | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20010042A2 HRP20010042A2 (en) | 2001-12-31 |
HRP20010042B1 true HRP20010042B1 (en) | 2011-03-31 |
Family
ID=8233832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010042A HRP20010042B1 (en) | 1998-06-19 | 2001-01-15 | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
Country Status (28)
Country | Link |
---|---|
US (3) | US6719979B2 (xx) |
EP (2) | EP0974660A1 (xx) |
JP (3) | JP2002518012A (xx) |
KR (1) | KR20010053000A (xx) |
CN (2) | CN101275142A (xx) |
AR (1) | AR020091A1 (xx) |
AT (1) | ATE367442T1 (xx) |
AU (1) | AU754844B2 (xx) |
BR (1) | BR9911383A (xx) |
CA (1) | CA2334165A1 (xx) |
CZ (1) | CZ300760B6 (xx) |
DE (1) | DE69936585T2 (xx) |
DK (1) | DK1088077T3 (xx) |
EA (1) | EA004796B1 (xx) |
ES (1) | ES2291029T3 (xx) |
HR (1) | HRP20010042B1 (xx) |
HU (1) | HUP0102429A3 (xx) |
ID (1) | ID27343A (xx) |
IL (2) | IL140381A0 (xx) |
NO (1) | NO329193B1 (xx) |
NZ (1) | NZ508982A (xx) |
PL (1) | PL197722B1 (xx) |
PT (1) | PT1088077E (xx) |
SI (1) | SI1088077T1 (xx) |
TR (1) | TR200100350T2 (xx) |
UA (1) | UA77146C2 (xx) |
WO (1) | WO1999066045A1 (xx) |
ZA (1) | ZA200100241B (xx) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0974660A1 (en) | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
US6146642A (en) * | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
US7244558B1 (en) * | 1999-05-05 | 2007-07-17 | University Of Maryland | Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines |
US10383936B2 (en) * | 1999-05-05 | 2019-08-20 | University Of Maryland, College Park | Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector |
CA2312626A1 (en) | 1999-07-27 | 2001-01-27 | Akzo Nobel N.V. | A recombinant newcastle disease virus as an embryo vaccine |
EP1074614B1 (en) * | 1999-07-27 | 2004-07-07 | Akzo Nobel N.V. | A recombinant Newcastle disease virus for in ovo vaccination |
ATE437223T1 (de) | 2000-06-23 | 2009-08-15 | Intervet Int Bv | Attenuiertes bovines respiratorisches syncytialvirus |
US7070789B2 (en) | 2000-11-02 | 2006-07-04 | Akzo Nobel N.V. | Recombinant Newcastle disease virus nucleoprotein mutant as a marker vaccine |
KR100437888B1 (ko) * | 2001-07-30 | 2004-07-03 | 주식회사 인트론바이오테크놀로지 | 뉴캐슬병 바이러스 검출용 프라이머 및 상기 프라이머를이용한 뉴캐슬병 바이러스 검출, 병원성 및 유전형 조사방법 |
US7615209B2 (en) | 2001-09-12 | 2009-11-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions of NDV and methods of use thereof for treatment of cancer |
IL145397A0 (en) * | 2001-09-12 | 2002-06-30 | Yissum Res Dev Co | Compositions and methods for treatment of cancer |
ATE307606T1 (de) | 2001-10-04 | 2005-11-15 | Ct Voor Onderzoek In Diergenee | Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung |
JP2005518209A (ja) * | 2002-02-21 | 2005-06-23 | マウント シナイ スクール オブ メディシン | 組換えマイナス鎖ウイルスrna発現系およびワクチン |
TW200502402A (en) * | 2002-12-06 | 2005-01-16 | Wyeth Corp | Escape mutants of newcastle disease virus as marker vaccines |
NZ543348A (en) | 2003-05-05 | 2008-08-29 | Thompson Boyce Plant Res | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
CN101123871B (zh) * | 2003-05-05 | 2011-05-18 | 美国陶氏益农公司 | 来源于转基因植物细胞的稳定免疫预防性和治疗性组合物及其制备方法 |
US7270990B2 (en) | 2003-06-20 | 2007-09-18 | Microbix Biosystems, Inc. | Virus production |
US7527638B2 (en) | 2003-12-16 | 2009-05-05 | Depuy Spine, Inc. | Methods and devices for minimally invasive spinal fixation element placement |
MY146476A (en) | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
GB0423681D0 (en) * | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
EP2292246A1 (en) | 2004-11-12 | 2011-03-09 | Bayer Schering Pharma Aktiengesellschaft | Recombinant Newcastle Disease Virus |
US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
US9216212B2 (en) * | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
GEP20135924B (en) * | 2005-12-02 | 2013-10-10 | The Mount Sinai School Of Medicine Of New York Univ | Chimeric viruses presenting non-native surface proteins and usage thereof |
WO2007106882A2 (en) * | 2006-03-15 | 2007-09-20 | Intervet International B.V. | Recombinant mononegaviral virus vectors |
JP2009529861A (ja) * | 2006-03-15 | 2009-08-27 | インターベツト・インターナシヨナル・ベー・ベー | 鳥インフルエンザウイルスのh5ヘマグルチニンを発現する組み換えニューキャッスル病ウイルス |
KR100776398B1 (ko) * | 2006-03-23 | 2007-11-28 | 주식회사 고려비엔피 | 조류 hn 단백질의 에피토프 및 상기 변이 에피토프를포함하는 뉴캐슬병 바이러스 |
KR100801180B1 (ko) | 2006-09-26 | 2008-02-05 | 주식회사 고려비엔피 | 약독화된 재조합 뉴캐슬병 바이러스 및 이를 함유하는뉴캐슬병 백신 |
KR100874256B1 (ko) | 2007-02-12 | 2008-12-16 | 대한민국 | 대장균 내독소 단백질 및 뉴캐슬병 바이러스뉴라미니데이즈 에피토프의 융합단백질 및 이의 용도 |
KR100955502B1 (ko) * | 2007-11-30 | 2010-04-30 | 대한민국 | 병원성 뉴캐슬병 바이러스 항체와 특이적으로 반응하는펩타이드 및 그의 용도 |
EP2085092A1 (en) | 2008-01-29 | 2009-08-05 | Bayer Schering Pharma Aktiengesellschaft | Attenuated oncolytic paramyxoviruses encoding avian cytokines |
US7794714B2 (en) * | 2008-03-14 | 2010-09-14 | The United States Of America As Represented By The Secretary Of Agriculture | Newcastle disease virus monoclonal antibodies |
US20090258035A1 (en) * | 2008-03-21 | 2009-10-15 | The United States Of America, As Represented By The Secretary Of Agriculture | Avian virus vaccines and uses thereof |
KR20110092316A (ko) * | 2008-11-19 | 2011-08-17 | 래보래토리오 아비-멕스, 에스.에이. 데 씨.브이. | 재조합 불활성화 바이러스 벡터 백신 |
WO2010091262A1 (en) | 2009-02-05 | 2010-08-12 | Mount Sinai School Of Medicine Of New York University | Chimeric newcastle disease viruses and uses thereof |
CA2771540C (en) | 2009-08-21 | 2019-01-15 | Merial Limited | Recombinant avian paramyxovirus vaccine and method for making and using thereof |
US20110110975A1 (en) * | 2009-11-06 | 2011-05-12 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
EP2327764B1 (en) | 2009-11-30 | 2011-12-28 | United Cancer Research Institute | New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
WO2012151391A2 (en) | 2011-05-04 | 2012-11-08 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
CN104321069A (zh) | 2011-10-27 | 2015-01-28 | 威尔斯达眼科制剂公司 | 编码视杆细胞来源的视锥细胞活力因子的载体 |
PL2785373T3 (pl) | 2011-11-30 | 2020-06-01 | Boehringer Ingelheim Animal Health USA Inc. | Rekombinowane wektory HVT wyrażające antygeny ptasich patogenów i ich zastosowania |
KR101374192B1 (ko) * | 2011-12-21 | 2014-03-14 | 대한민국 | 제4형 조류파라믹소바이러스 hn 단백질 및 이를 포함하는 hi법 검사용 항원진단액 |
NZ711946A (en) | 2013-03-14 | 2020-05-29 | Icahn School Med Mount Sinai | Newcastle disease viruses and uses thereof |
CN104059942B (zh) * | 2013-03-20 | 2016-12-28 | 湖北省农业科学院畜牧兽医研究所 | 新城疫病毒耐热活疫苗载体系统及其应用 |
US20140341950A1 (en) * | 2013-05-15 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Recombinant avian paramyxovirus vaccine and method for making and using thereof |
EP3441084A1 (en) | 2014-02-27 | 2019-02-13 | Viralytics Limited | Oncolytic virus and immuno-stimulatory agent for combined use in the treatment of cancer |
WO2017087550A1 (en) | 2015-11-16 | 2017-05-26 | Georgia State University Research Foundation, Inc. | Tunable vaccine platform against pathogens of the paramyxovirus family |
CA3012703A1 (en) | 2016-02-03 | 2017-08-10 | Cg Discovery, Inc. | Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites |
US10063211B2 (en) * | 2016-02-03 | 2018-08-28 | Qualcomm Incorporated | Compact bypass and decoupling structure for millimeter-wave circuits |
US10196616B2 (en) | 2017-02-15 | 2019-02-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Altered avian virus for in-ovo inoculation and methods of use thereof |
BR112020013426A2 (pt) * | 2018-02-28 | 2020-12-01 | Regeneron Pharmaceuticals, Inc. | métodos para identificação de um vírus em uma amostra e para detecção de ácidos nucleicos virais em uma amostra de cultura de células |
CN109735552A (zh) * | 2019-02-27 | 2019-05-10 | 苏州世诺生物技术有限公司 | 禽新城疫病毒新型基因工程亚单位疫苗 |
CN110018304A (zh) * | 2019-05-15 | 2019-07-16 | 河南省农业科学院 | 一种新城疫抗体阻断检测试纸 |
CN110240635B (zh) * | 2019-06-10 | 2022-04-22 | 华中农业大学 | 检测新城疫病毒抗体的多肽及其elisa检测试剂盒 |
CN110257562A (zh) * | 2019-07-31 | 2019-09-20 | 河北农业大学 | 一种raa-lfd检测鸡传染性喉气管炎病毒的引物和探针组合及其应用 |
KR102154796B1 (ko) * | 2019-10-18 | 2020-09-22 | 주식회사 바이오포아 | 변이 뉴캣슬병 바이러스 및 상기 바이러스를 이용한 조류 백신 |
CN110938711A (zh) * | 2019-12-20 | 2020-03-31 | 河北农业大学 | 一种检测鸡传染性喉气管炎病毒的实时荧光raa引物和探针、试剂盒及其使用方法 |
CN111334528B (zh) * | 2020-03-20 | 2022-02-18 | 山东农业大学 | 水貂肠炎细小病毒全基因组感染性克隆及其构建方法和应用 |
CN112048484A (zh) * | 2020-07-27 | 2020-12-08 | 华南农业大学 | 一株表达传染性法氏囊强毒株vp2蛋白的基因ⅶ型新城疫重组病毒和疫苗 |
CN114214338B (zh) * | 2021-08-26 | 2023-02-03 | 扬州大学 | 猪源piv5全长感染性克隆及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0780475A1 (en) * | 1995-08-09 | 1997-06-25 | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU602875B2 (en) * | 1985-12-18 | 1990-11-01 | British Technology Group Limited | Newcastle disease virus gene clones |
ES2210273T5 (es) * | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
JPH11507241A (ja) * | 1995-06-07 | 1999-06-29 | シントロ・コーポレーション | 組換え鶏痘ウイルスおよびその使用 |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0974660A1 (en) | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
US6146642A (en) | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
-
1998
- 1998-06-19 EP EP98202054A patent/EP0974660A1/en not_active Withdrawn
-
1999
- 1999-06-17 ES ES99926984T patent/ES2291029T3/es not_active Expired - Lifetime
- 1999-06-17 PT PT99926984T patent/PT1088077E/pt unknown
- 1999-06-17 IL IL14038199A patent/IL140381A0/xx active IP Right Grant
- 1999-06-17 AU AU43991/99A patent/AU754844B2/en not_active Ceased
- 1999-06-17 DE DE69936585T patent/DE69936585T2/de not_active Expired - Lifetime
- 1999-06-17 EP EP99926984A patent/EP1088077B2/en not_active Expired - Lifetime
- 1999-06-17 AT AT99926984T patent/ATE367442T1/de active
- 1999-06-17 JP JP2000554854A patent/JP2002518012A/ja not_active Withdrawn
- 1999-06-17 SI SI9930990T patent/SI1088077T1/sl unknown
- 1999-06-17 HU HU0102429A patent/HUP0102429A3/hu unknown
- 1999-06-17 CN CNA2008100921449A patent/CN101275142A/zh active Pending
- 1999-06-17 EA EA200100057A patent/EA004796B1/ru not_active IP Right Cessation
- 1999-06-17 CA CA002334165A patent/CA2334165A1/en not_active Abandoned
- 1999-06-17 UA UA2001010408A patent/UA77146C2/uk unknown
- 1999-06-17 WO PCT/NL1999/000377 patent/WO1999066045A1/en active IP Right Grant
- 1999-06-17 KR KR1020007014397A patent/KR20010053000A/ko not_active Application Discontinuation
- 1999-06-17 DK DK99926984T patent/DK1088077T3/da active
- 1999-06-17 PL PL348300A patent/PL197722B1/pl not_active IP Right Cessation
- 1999-06-17 ID IDW20010146A patent/ID27343A/id unknown
- 1999-06-17 CZ CZ20004707A patent/CZ300760B6/cs not_active IP Right Cessation
- 1999-06-17 BR BR9911383-0A patent/BR9911383A/pt not_active IP Right Cessation
- 1999-06-17 CN CN99809714A patent/CN1314942A/zh active Pending
- 1999-06-17 NZ NZ508982A patent/NZ508982A/en unknown
- 1999-06-17 TR TR2001/00350T patent/TR200100350T2/xx unknown
- 1999-06-18 AR ARP990102948A patent/AR020091A1/es not_active Application Discontinuation
-
2000
- 2000-12-15 NO NO20006406A patent/NO329193B1/no not_active IP Right Cessation
- 2000-12-18 IL IL140381A patent/IL140381A/en not_active IP Right Cessation
- 2000-12-19 US US09/741,744 patent/US6719979B2/en not_active Expired - Fee Related
-
2001
- 2001-01-09 ZA ZA2001/00241A patent/ZA200100241B/en unknown
- 2001-01-15 HR HR20010042A patent/HRP20010042B1/xx not_active IP Right Cessation
-
2004
- 2004-02-26 US US10/788,232 patent/US7332169B2/en not_active Expired - Fee Related
- 2004-04-15 US US10/824,782 patent/US7547442B2/en not_active Expired - Fee Related
-
2005
- 2005-12-01 JP JP2005347888A patent/JP2006141398A/ja active Pending
-
2009
- 2009-02-04 JP JP2009023349A patent/JP2009261387A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0780475A1 (en) * | 1995-08-09 | 1997-06-25 | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20010042B1 (en) | Newcastle disease virus infectious clones, vaccines and diagnostic assays | |
CA2366072A1 (en) | Prrsv vaccines | |
HUP9903829A3 (en) | Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof | |
HUP0303036A3 (en) | Dna transfection system for the generation of infectious influenza virus | |
ATE287728T1 (de) | Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren | |
BR9710012A (pt) | Vacina viva recombinante à base de herpesvírus canino notadamente contra o mal de carré a raiva ou o vírus parainfluenza do tipo 2 | |
BR9807873A (pt) | Vacinas de flavivìrus quiméricos | |
DE69532369D1 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus | |
HUP0302265A2 (hu) | Rekombináns Newcastle-betegségvírus nukleoprotein-mutánsa markervakcinaként alkalmazva | |
DE69839169D1 (de) | Aus infektiöser cDNA gewonnene rekombinate YF Viren-Impfstoffe | |
AR040996A1 (es) | Acidos nucleicos inmunoestimuladores | |
DE69533305D1 (de) | Lebende rekombinante Vogelvakzine auf eines Vogelherpesvirus gegründet, gegen Gumborokrankheit | |
BR0016145A (pt) | Clones infecciosos | |
BR0012433A (pt) | Vìrus recombinante, infeccioso de doença bursal infecciosa, método para obter o mesmo, ibdv mosaico infeccioso (mibdv), e, vacina | |
EA200701633A1 (ru) | Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1 | |
BR0102322A (pt) | Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus | |
BR9915703B1 (pt) | mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva. | |
HUP0101652A1 (hu) | Új kompozíció | |
ES2153284B1 (es) | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. | |
EP1296710A4 (en) | RECOMBINANT VACCINES AGAINST INFECTIOUS BURSITY VIRUS | |
AU1674200A (en) | Dna vaccine against infectious bursal disease virus | |
DE69029145T2 (de) | Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus | |
IT1295542B1 (it) | Bocchetta di presa d'aria anti-vento | |
HU0102823D0 (en) | A broad spectrum infectious bursal disease virus vaccine | |
IL179422A0 (en) | Recombinant vaccines against infectious bursal disease virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
PPPP | Transfer of rights |
Owner name: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK, NL |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110614 Year of fee payment: 13 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20120618 |